These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 28644953)

  • 1. Helping Induced hPSCs Clean Up Their Act.
    Jeong HC; Cha HJ
    Cell Chem Biol; 2017 Jun; 24(6):651-652. PubMed ID: 28644953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient, Selective Removal of Human Pluripotent Stem Cells via Ecto-Alkaline Phosphatase-Mediated Aggregation of Synthetic Peptides.
    Kuang Y; Miki K; Parr CJC; Hayashi K; Takei I; Li J; Iwasaki M; Nakagawa M; Yoshida Y; Saito H
    Cell Chem Biol; 2017 Jun; 24(6):685-694.e4. PubMed ID: 28529132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical decontamination of iPS cell-derived neural cell mixtures.
    Mao D; Chung XKW; Andoh-Noda T; Qin Y; Sato SI; Takemoto Y; Akamatsu W; Okano H; Uesugi M
    Chem Commun (Camb); 2018 Feb; 54(11):1355-1358. PubMed ID: 29350722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria in human pluripotent stem cell apoptosis.
    TeSlaa T; Setoguchi K; Teitell MA
    Semin Cell Dev Biol; 2016 Apr; 52():76-83. PubMed ID: 26828436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder-free system.
    Lu HE; Tsai MS; Yang YC; Yuan CC; Wang TH; Lin XZ; Tseng CP; Hwang SM
    Exp Cell Res; 2011 Aug; 317(13):1895-903. PubMed ID: 21640101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoactivable Elimination of Tumorigenic Human Induced Pluripotent Stem Cells by Using a Lectin-Doxorubicin Prodrug Conjugate.
    Dion J; Minoshima F; Saito S; Kiyoi K; Hasehira K; Tateno H
    Chembiochem; 2019 Jun; 20(12):1606-1611. PubMed ID: 30737871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.
    Abraham S; Sheridan SD; Miller B; Rao RR
    Biotechnol Prog; 2010; 26(4):1126-34. PubMed ID: 20730767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering Strategies for the Formation of Embryoid Bodies from Human Pluripotent Stem Cells.
    Pettinato G; Wen X; Zhang N
    Stem Cells Dev; 2015 Jul; 24(14):1595-609. PubMed ID: 25900308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel live alkaline phosphatase substrate for identification of pluripotent stem cells.
    Singh U; Quintanilla RH; Grecian S; Gee KR; Rao MS; Lakshmipathy U
    Stem Cell Rev Rep; 2012 Sep; 8(3):1021-9. PubMed ID: 22426885
    [No Abstract]   [Full Text] [Related]  

  • 11. Haematopoietic developmental potential of human pluripotent stem cell lines.
    Tesařová L; Simara P; Stejskal S; Koutná I
    Folia Biol (Praha); 2014; 60 Suppl 1():90-4. PubMed ID: 25369348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased culture density is linked to decelerated proliferation, prolonged G1 phase, and enhanced propensity for differentiation of self-renewing human pluripotent stem cells.
    Wu J; Fan Y; Tzanakakis ES
    Stem Cells Dev; 2015 Apr; 24(7):892-903. PubMed ID: 25405279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging-cytometry revealed spatial heterogeneities of marker expression in undifferentiated human pluripotent stem cells.
    Suga M; Tachikawa S; Tateyama D; Ohnuma K; Furue MK
    In Vitro Cell Dev Biol Anim; 2017 Jan; 53(1):83-91. PubMed ID: 27573412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States.
    Chen RJ; Zhang G; Garfield SH; Shi YJ; Chen KG; Robey PG; Leapman RD
    PLoS One; 2015; 10(11):e0142554. PubMed ID: 26565809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene targeting in human pluripotent stem cells.
    Liu Y; Rao M
    Methods Mol Biol; 2011; 767():355-67. PubMed ID: 21822888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cGMP-Compliant Expansion of Human iPSC Cultures as Adherent Monolayers.
    Parr AM; Walsh PJ; Truong V; Dutton JR
    Methods Mol Biol; 2016; 1357():221-9. PubMed ID: 25863788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage.
    Medvedev SP; Grigor'eva EV; Shevchenko AI; Malakhova AA; Dementyeva EV; Shilov AA; Pokushalov EA; Zaidman AM; Aleksandrova MA; Plotnikov EY; Sukhikh GT; Zakian SM
    Stem Cells Dev; 2011 Jun; 20(6):1099-112. PubMed ID: 20846027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Megakaryocytes and Platelets from Human Pluripotent Stem Cells.
    Pick M
    Methods Mol Biol; 2016; 1307():371-8. PubMed ID: 24297316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical-scale purification of pluripotent stem cell derivatives for cell-based therapies.
    Rodrigues GM; Rodrigues CA; Fernandes TG; Diogo MM; Cabral JM
    Biotechnol J; 2015 Aug; 10(8):1103-14. PubMed ID: 25851544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.